Carmat Future Growth
Future criteria checks 5/6
Carmat is forecast to grow earnings and revenue by 43.7% and 52.9% per annum respectively while EPS is expected to grow by 52.4% per annum.
Key information
43.7%
Earnings growth rate
52.4%
EPS growth rate
| Medical Equipment earnings growth | 15.9% |
| Revenue growth rate | 52.9% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 01 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 68 | -21 | -24 | -27 | 5 |
| 12/31/2025 | 27 | -37 | -45 | -33 | 6 |
| 12/31/2024 | 10 | -42 | -47 | -42 | 4 |
| 6/30/2024 | 7 | -53 | -53 | -49 | N/A |
| 3/31/2024 | 5 | -54 | -56 | -51 | N/A |
| 12/31/2023 | 4 | -54 | -59 | -53 | N/A |
| 9/30/2023 | 2 | -54 | -58 | -54 | N/A |
| 6/30/2023 | 1 | -54 | -57 | -55 | N/A |
| 3/31/2023 | 1 | -54 | -57 | -55 | N/A |
| 12/31/2022 | 0 | -54 | -56 | -54 | N/A |
| 9/30/2022 | 1 | -58 | -60 | -58 | N/A |
| 6/30/2022 | 2 | -62 | -63 | -61 | N/A |
| 3/31/2022 | 2 | -62 | -62 | -61 | N/A |
| 12/31/2021 | 2 | -62 | -62 | -60 | N/A |
| 9/30/2021 | 1 | -52 | -59 | -56 | N/A |
| 6/30/2021 | 0 | -42 | -55 | -53 | N/A |
| 3/31/2021 | 0 | -40 | -50 | -48 | N/A |
| 12/31/2020 | 0 | -37 | -45 | -43 | N/A |
| 9/30/2020 | 0 | -38 | -41 | -40 | N/A |
| 6/30/2020 | 0 | -40 | -38 | -37 | N/A |
| 3/31/2020 | 0 | -41 | -39 | -39 | N/A |
| 12/31/2019 | 0 | -43 | -41 | -40 | N/A |
| 9/30/2019 | 0 | -45 | -42 | -41 | N/A |
| 6/30/2019 | 0 | -47 | -43 | -42 | N/A |
| 3/31/2019 | 0 | -44 | -42 | -40 | N/A |
| 12/31/2018 | 0 | -42 | -40 | -38 | N/A |
| 9/30/2018 | 0 | -38 | -37 | -34 | N/A |
| 6/30/2018 | 0 | -34 | -34 | -30 | N/A |
| 3/31/2018 | 0 | -32 | N/A | -27 | N/A |
| 12/31/2017 | 0 | -29 | N/A | -24 | N/A |
| 9/30/2017 | 0 | -28 | N/A | -25 | N/A |
| 6/30/2017 | 0 | -27 | N/A | -26 | N/A |
| 3/31/2017 | 0 | -25 | N/A | -23 | N/A |
| 12/31/2016 | 0 | -23 | N/A | -21 | N/A |
| 9/30/2016 | 0 | -21 | N/A | -20 | N/A |
| 6/30/2016 | 0 | -20 | N/A | -19 | N/A |
| 3/31/2016 | 0 | -19 | N/A | -18 | N/A |
| 12/31/2015 | 0 | -18 | N/A | -17 | N/A |
| 9/30/2015 | 0 | -17 | N/A | -17 | N/A |
| 6/30/2015 | N/A | -17 | N/A | -17 | N/A |
| 3/31/2015 | 0 | -17 | N/A | -18 | N/A |
| 12/31/2014 | 0 | -18 | N/A | -19 | N/A |
| 9/30/2014 | 0 | -19 | N/A | -17 | N/A |
| 6/30/2014 | 0 | -20 | N/A | -15 | N/A |
| 3/31/2014 | 1 | -17 | N/A | -12 | N/A |
| 12/31/2013 | 3 | -15 | N/A | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CXT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.8%).
Earnings vs Market: CXT is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CXT is expected to become profitable in the next 3 years.
Revenue vs Market: CXT's revenue (52.9% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: CXT's revenue (52.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CXT's Return on Equity is forecast to be high in 3 years time